| Also known as |
DFMO, difluoromethylornithine |
| Blood pressure |
No significant effects |
| Chemical name |
(RS)-2,5-Diamino-2-(difluoromethyl)pentanoic acid hydrochloride |
| Dosage (medical) |
For hirsutism, apply a thin layer of 13.9% cream to affected areas twice daily, for sleeping sickness, 400 mg intravenously every 6 hours for 14 days |
| Dosage (sports) |
Not applicable |
| Effects |
Reduces rate of hair growth, treats protozoal infections |
| Formula |
C6H12F2N2O2В·HCl |
| Half-life |
8 hours |
| Hepatotoxicity |
Low risk |
| Lab Test |
Not typically required for monitoring |
| Main action |
Inhibits hair growth and treats African trypanosomiasis (sleeping sickness) |
| Side effects |
Stinging skin, rash, redness, burning, acneiform eruptions |
| Storage conditions |
Store at room temperature, away from light and moisture |
| Substance class |
Antiprotozoal, irreversible inhibitor of ornithine decarboxylase |
| Trade name |
Vaniqa, Ornidyl |
| Use in sports |
Not typically used in sports |
| Water Retention |
No known water retention effects |
| Manufacturer |
Ranbaxy |
